Assembly Biosciences announces pricing of $175 million in equity financings

3 hours ago 1

Healthcare

Comments

Assembly Biosciences (NASDAQ:ASMB) on Friday reported the pricing of a public offering that includes:

5,591,840 shares of common stock,
Pre-funded warrants to purchase up to 1,040,820 additional shares,
Class A and Class B warrants to purchase up to 6,632,660 shares

Recommended For You

More Trending News

Read Entire Article